Back
Top 0.3%
23.1%
Top 6%
12.3%
Top 3%
6.2%
Top 74%
6.2%
Top 4%
6.2%
Top 1%
6.1%
Top 65%
4.0%
Top 0.9%
4.0%
Top 1%
4.0%
#1
2.9%
Top 2%
2.0%
Top 5%
2.0%
Top 6%
2.0%
Top 3%
1.6%
Top 3%
1.4%
Top 4%
1.4%
Top 4%
1.0%
Top 8%
0.7%
Top 6%
0.7%
Top 29%
0.7%
Top 4%
0.7%
LncRNA CDKN2B-AS1 C-Allele: A High-Risk Genetic Determinant in Cancer Susceptibility and Progression Impacting Immune Cell Modulation Dynamics with Therapeutic Implications
2026-01-08
oncology
Title + abstract only
View on medRxiv
Show abstract
Examining LncRNA-driven cancer biology, our study represents the first comprehensive investigation of the LncRNA CDKN2B-AS1 across multiple cancer types, revealing its genetic basis for cancer susceptibility, and associations with thromboembolic risks and immunological dynamics. Stratification across hematological and non-hematological cancers revealed predominant prevalence rates of the CDKN2B-AS1 C-allele, notably higher in solid tumor malignancies, peaking at 86.8% in colorectal carcinoma (CR...
Predicted journal destinations
1
Cancers
57 training papers
2
Nature Communications
483 training papers
3
Frontiers in Oncology
34 training papers
4
PLOS ONE
1737 training papers
5
eLife
262 training papers
6
Clinical Cancer Research
22 training papers
7
Scientific Reports
701 training papers
8
Cancer Medicine
17 training papers
9
British Journal of Cancer
22 training papers
10
Cell Reports
25 training papers
11
iScience
74 training papers
12
Proceedings of the National Academy of Sciences
100 training papers
13
Frontiers in Immunology
140 training papers
14
BMC Cancer
21 training papers
15
Cell Reports Medicine
49 training papers
16
Nature
58 training papers
17
Journal of Clinical Investigation
50 training papers
18
Genome Medicine
56 training papers
19
International Journal of Molecular Sciences
39 training papers
20
JAMA Network Open
125 training papers
21
Communications Biology
36 training papers